InvestorsHub Logo
Followers 18
Posts 6644
Boards Moderated 0
Alias Born 03/06/2010

Re: mrwrn2010 post# 389665

Saturday, 10/21/2023 11:14:40 AM

Saturday, October 21, 2023 11:14:40 AM

Post# of 401526
Agreed, with mid-November Q2 fiscal results release and hopefully generic OxyContin news around time of antimetabolite approval. Will be good next 6 months. I’m eager to hear how R&D pipeline is getting replenished, upcoming filings (excl gen Vyvanse). I expect generic Concerta to be on deck for bioequivalency w/ filing 1H 2024. After this is filed, we don’t have ton of insight into next big opportunities.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News